Cite
HARVARD Citation
Bohula, E. et al. (2018). Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet. 392 (10161), pp. 2269-2279. [Online].